The limited reporting of adverse effects in neonatal transfusion trials, the quality of the studies identified as well as the risk of bias inherent in studies in this area are likely to be significant limitations to our review [ 9 ].
← all excerpts
Adverse effects of small-volume red blood cell transfusions in the neonatal population.
1
—
—